Majority of the studies have shown that circulating levels of omentin are decreased in individuals with obesity and T2D [10–13] and positively associated with flow-mediated vasodilatation [14,15] suggesting a protective role of human omentin on cardiometabolic health. Here, ITLN1 is linked to type 2 diabetes mellitus.